20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
MindBio Therapeutics Corp. (CSE:MBIO) (Frankfurt:WF6) have started pre-screening for participant entry into phase 2 LSD-microdosing clinical trials. The clinical trials are a for take home use of MindBio's LSD-microdosing treatment. The initial phase 2a open label trial will assess the treatment in patients with major depressive disorder for 8 weeks.
MindBio's LSD-Microdosing clinical trials to date have yielded positive top line data such as improved quality of sleep including REM and total time of sleep and statistically significant enhancements in subjective feelings of "wellness", "creativity", "happiness", "social connectivity" and "energy". Participants in the LSD-Microdosing group also reported statistically significant feelings of being less "angry" and less "irritable".
Co-founder and CEO of MindBio Therapeutics Justin Hanka stated "We are excited to be progressing our LSD-Microdosing protocols through to phase 2 clinical trials in patients with major depressive disorder. The positive data we have collected to date is highly encouraging for targeting depressed patients with diminished mood and disrupted sleep".
Benzinga Cannabis Capital Conference
The Benzinga Cannabis Capital Conference, the place where deals get done, is returning to Chicago this Sept 27-28 for its 17th edition. Get your tickets today before prices increase and secure a spot at the epicenter of cannabis investment and branding.
Photo: Benzinga edit with photos by fizkes and olesea vetrila on Shutterstock
Related News
Microdosing LSD For Major Depression Treatment Seeks Further Clinical Validation Via New Study
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!